Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Scinai Immunotherapeutics Ltd.

Market Cap 1.44M 1.24M 1.14M 1.07M 2.02M 136M 2.04M 13.53M 5.29M 66.78M 5.41M 5.3M 231M P/E Ratio 2024 *
-
P/E Ratio 2025 -0.2x
Enterprise Value 2.05M 1.77M 1.63M 1.52M 2.86M 194M 2.89M 19.21M 7.51M 94.83M 7.69M 7.53M 328M EV / Sales 2024
4,521,684x
EV / Sales 2025 2,346,088x
Free-Float
0.36%
Yield 2024 *
-
Yield 2025 -
1 day-7.24%
1 week-1.21%
Current month-22.22%
1 month-37.50%
3 months-50.00%
6 months-58.33%
Current year-50.85%
1 week 0.3
Extreme 0.3001
0.39
1 month 0.3
Extreme 0.3001
0.58
Current year 0.3
Extreme 0.3001
1.12
1 year 0.3
Extreme 0.3001
3.48
3 years 0.3
Extreme 0.3001
18.7
5 years 0.3
Extreme 0.3001
419
10 years 0.3
Extreme 0.3001
6,199.99
Manager TitleAgeSince
Chief Executive Officer 51 02/03/2021
Director of Finance/CFO 54 01/01/2007
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 77 30/09/2019
Director/Board Member 64 24/03/2020
Director/Board Member 71 24/03/2020
Date Insider Type Main position Quantity % Market Cap.
03-18Other

Chief Operating Officer

173,816,000 5.0943%
03-18Other

Director

57,400,000 1.6823%
03-18Other

Director

60,400,000 1.7702%
Change 5-day change 1-year change 3-year change Capi.($)
-7.24%-1.21%-84.09%-97.60% 1.44M
-0.12%-0.18%-12.80%-12.90% 43.58B
-3.31%+3.34%+288.58%+527.70% 34.03B
+0.10%-4.35%+11.87%-17.53% 29.77B
-0.28%-0.28%+1.13%+33.57% 29.82B
-0.29%+9.47%+13.95%+21.93% 25.42B
+2.68%+7.57% - - 13.87B
-1.25%-1.19%+53.25%+107.94% 13.35B
-1.04%-3.48%+2.42%+1.98% 12.85B
-1.51%-2.37%+106.63%+77.51% 12.22B
Average -1.20%+0.77%+42.33%+71.40% 21.49B
Weighted average by Cap. -0.68%+2.02%+59.93%+103.68%

Financials

2024 2025
Net sales 0.66 0.57 0.52 0.49 0.92 62.19 0.93 6.17 2.41 30.45 2.47 2.42 105.38 1.31 1.13 1.04 0.98 1.83 123.9 1.85 12.29 4.8 60.67 4.92 4.82 209.95
Net income 4.8M 4.13M 3.8M 3.57M 6.7M 453M 6.77M 44.98M 17.57M 222M 18M 17.62M 768M -8.31M -7.16M -6.59M -6.18M -11.61M -785M -11.73M -77.9M -30.43M -384M -31.17M -30.51M -1.33B
Net Debt 122K 105K 96.78K 90.79K 171K 11.53M 172K 1.14M 447K 5.65M 458K 448K 19.54M 606K 522K 481K 451K 847K 57.27M 856K 5.68M 2.22M 28.05M 2.27M 2.23M 97.05M
Logo Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Employees
45
Date Price Change Volume
16/06/26 0.3500 $ -3.95% 348,737
15/06/26 0.3644 $ +10.09% 2,640,995
12/06/26 0.3310 $ +1.81% 1,229,342
11/06/26 0.3251 $ -0.58% 157,293
10/06/26 0.3270 $ -7.71% 345,288

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCNI Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!